H.R. 7658 — To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Summary

This bill reauthorizes through FY2027 the Food and Drug Administration's Critical Path Public-Private Partnerships, which support medical product innovation, development, and safety.

Full Text

Legislative Actions

2022-05-03
Introduced in House
2022-05-03
Introduced in House
2022-05-03
Referred to the House Committee on Energy and Commerce.

To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Sponsors

Subjects

Summary

Full Text

Legislative Actions

Ask about this bill